Brands

<h2 dir="ltr">What Are Adenoviral Cloning Vectors?</h2>
 An adenoviral shuttle plasmid (transfer vector) contains a transgene expression cassette flanked by adenoviral genomic sequences that mediate recombination into the full adenoviral backbone genome. This shuttle plasmid is the starting point for constructing any custom recombinant adenovirus. Successful adenoviral studies begin with the appropriate cloning backbone. Choose a vector compatible with your development workflow.
&nbsp;
<h2 dir="ltr">What you will find:</h2>
&nbsp;
<ul>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif;" aria-level="1">
pShuttle backbone vectors, including pShuttle(+), pShuttle(-), and pShuttle-His variants for gene insertion and adenoviral construct assembly&nbsp;
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif;" aria-level="1">
Tagged expression vectors such as pShuttle-His-18x and pShuttle-2A-RFP for co-expression and protein labeling studies
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif;" aria-level="1">
Functional assay and reporter vectors, including pPromoter and pSiShuttle for transcriptional analysis and gene regulation&nbsp;
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif;" aria-level="1">
Ready-to-use adenoviral DNA for simplified preparation of constructs
</li>
</ul>
<h2 dir="ltr"> How to Choose an Adenoviral Cloning Vector</h2>
 Promoter Selection CMV, EF1&alpha;, and CAG promoter options are available for driving transgene expression &mdash; CMV offers strong, broadly active expression, while EF1&alpha; and CAG can provide more consistent expression in certain cell types. Cloning Method Compatibility Gateway-compatible backbones enable site-specific recombination cloning without restriction enzymes, useful for parallel construct generation. Standard multiple cloning sites (MCS) with conventional restriction sites remain available for traditional cloning workflows. Deletion Configuration E1/E3-deleted Ad5 backbones are the standard configuration &mdash; E1 deletion renders the virus replication-deficient, while E3 deletion provides additional cloning capacity. Downstream Production Pathway The shuttle plasmid recombines into the full adenoviral genome during virus production &mdash; selecting a shuttle vector compatible with your packaging cell line and downstream amplification approach avoids compatibility issues later in the workflow. Reporter/Selection Inclusion Shuttle vectors with fluorescent reporters (GFP) or selection markers built into the cassette simplify confirmation of successful cloning and subsequent virus packaging steps. 
<h2 dir="ltr"> Specifications Context</h2>
 After cloning the transgene into an adenoviral shuttle plasmid, the construct is recombined into the full adenoviral backbone genome in packaging systems or recombination-based workflows, followed by amplification in complementing cell lines to generate recombinant adenoviral stocks. Gateway-compatible shuttle vectors enable transfer of validated entry clones into the adenoviral system without re-cloning. Sequence verification of the shuttle construct by restriction analysis or sequencing is recommended before recombination to ensure construct integrity. Product availability reflects MBP&rsquo;s catalogue as of mid-2026. 
&nbsp;
<a href="https://mbpinc.net/contact-us">Contact the expert team </a>at MBP for guidance on shuttle vector selection based on promoter configuration and experimental design requirements.

Cloning Vectors

Selection-Drug Killing Curve

Adenovirus-2-Expression-Protocol

pShuttle-HA

Unit Quantity

Vector

Note

Shipping Condition

pShuttle-His

pShuttle-His-18x Vector

<h2 dir="ltr">What Are Adenoviral Control &amp; Reporter Constructs?</h2>
 Adenoviral over-expression experiments typically include matched control constructs that use the same vector backbone, promoter configuration, and production workflow as the experimental construct, and are packaged and purified under equivalent conditions. This helps account for vector-related and adenovirus-associated innate immune responses that can influence cellular readouts independently of the transgene. Using appropriate null or reporter controls is essential for accurate interpretation of adenoviral transduction and expression data. Choose the tools that support accurate data interpretation.
&nbsp;
<h2 dir="ltr">What you will find:</h2>
&nbsp;
<ul>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif;" aria-level="1">
GFP Adenovirus Reporters: confirm transduction visually using high-titer viral particles expressing green fluorescent protein
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif; color: #000000;" aria-level="1">
Beta-Galactosidase (LacZ) Adenoviruses: &beta;-gal markers derived from E. coli for standardized colorimetric and histochemical assays.
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif; color: #000000;" aria-level="1">
pShuttle-LacZ Control Vectors: produce recombinant adenoviruses expressing LacZ.
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif; color: #000000;" aria-level="1">
Null Adenovirus Controls: empty viral particles for assessment of non-specific cellular responses during gene delivery.
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif; color: #000000;" aria-level="1">
CMV Null Adenoviruses: used to identify promoter-specific metabolic effects. Contains CMV promoter without a transgene.
</li>
</ul>
<h2 dir="ltr"> How to Choose Adenoviral Control &amp; Reporter Constructs</h2>
 Empty Vector Matching An empty vector control &mdash; identical backbone, promoter, and packaging as the experimental adenoviral construct, with no transgene insert &mdash; establishes the baseline for adenoviral delivery effects independent of the over-expressed gene. Fluorescent Reporter Selection GFP and RFP fluorescent reporters allow tracking of transduction efficiency by microscopy or flow cytometry, matching the promoter configuration of experimental constructs. Luciferase Reporter Format Firefly luciferase and Renilla luciferase provide quantitative bioluminescent readouts; secreted NanoLuc reporters allow sampling of culture supernatant for repeated, non-destructive measurements over a time course. Immune Activation Considerations Because adenoviral delivery activates innate immune sensing in transduced cells independently of any transgene, an identical-backbone control is essential to distinguish transgene-specific effects from generalised adenoviral response. Production Workflow Matching Controls should be produced, packaged, and purified using the same protocol and timeline as experimental constructs to avoid batch-to-batch variability confounding comparisons. 
<h2 dir="ltr"> Specifications Context</h2>
 Adenoviral delivery can activate innate immune sensing in transduced cells, altering gene expression independently of the transgene; therefore, matched controls with the same Ad5 backbone and promoter configuration are required for valid interpretation of adenoviral over-expression experiments. MBP adenoviral control and reporter constructs include GFP adenovirus, &beta;-gal (LacZ) adenovirus, and null adenovirus systems, supporting qualitative and quantitative assessment of transduction efficiency. Using control and experimental constructs produced under consistent conditions reduces variability that can confound downstream comparisons across treatment groups. Recording vector identity and batch information supports reproducibility and troubleshooting. Product availability reflects MBP&rsquo;s catalogue as of mid-2026. 
&nbsp;
<a href="https://mbpinc.net/contact-us">Contact the expert team</a> at MBP today for the selection of matched adenoviral control and reporter constructs for your workflow.

Control/Reporter

Lentiviral Vector Amplification Protocol

AAV Infection Guideline

AAV Packaging Protocol

Lentivector Packaging Protocol

Lentivirus Infection Protocol

pShuttle-LacZ control vector

pSiShuttle Vector

<h2 dir="ltr">What is a qPCR, Titer Kit?</h2>
 A qPCR titer kit provides the primers, probes, or dye-based detection chemistry, standards, and master mix components needed to quantify viral vector genome copy number by real-time PCR. For lentiviral preparations, this typically involves amplifying a conserved region of the viral genome (such as the LTR or a packaging signal sequence) and comparing the signal to a standard curve of known copy number to determine vector genomes per mL of the preparation. Use a qPCR titer kit for rapid, same-day genomic titer determination of in-house viral vector preparations, understanding that genomic titer (genome copies/mL) is related to, but distinct from, functional (infectious) titer measured by transduction assays.
&nbsp;
<h2 dir="ltr">What you will find:</h2>
&nbsp;
<ul>
<li dir="ltr" aria-level="1">
Lentivirus &amp; Retrovirus Titer Kits: Advanced quantitative qPCR-based tools designed for rapid and accurate assessment of viral genome copy number in lentiviral and retroviral preparations, supporting consistent transduction workflow optimisation in mammalian cell culture systems.
</li>
<li dir="ltr" aria-level="1">
AAV Titer Kits: Optimised qPCR solutions for the quantification of Adeno-Associated Virus vectors, providing precise genome copy data required for vector dosing and therapeutic research studies.
</li>
</ul>
<h2 dir="ltr"> How to Choose a qPCR Titer Kit</h2>
 Viral Vector Type Compatibility qPCR titer kits are commonly available for lentivirus, with related kits for AAV and other viral vector types -- confirm the kit targets the appropriate conserved genomic region for your specific vector type and packaging system. Genomic vs. Functional Titer qPCR titer kits report genomic titer (vector genome copies per mL), which can differ from functional or infectious titer measured by transduction-based assays (such as a GFP or antibiotic-resistance endpoint assay) -- understanding this distinction is important when translating a qPCR titer result into an experimental MOI. Standard Curve and Quantification Range The kit's included standards define the quantification range over which results are reliable -- confirm your expected titer falls within this range, diluting samples as needed to bring concentrated preparations into range. Turnaround Time qPCR titer kits provide same-day results (the time required for a qPCR run plus data analysis), substantially faster than functional transduction-based titer assays, which require a transduction step followed by several days of cell culture and an endpoint readout. Compatibility with Existing qPCR Infrastructure Since qPCR titer kits use standard real-time PCR instrumentation, confirm that the kit's detection chemistry (dye-based or probe-based) and any reference dye requirements (such as ROX) are compatible with your existing real-time PCR instrument. 
<h2 dir="ltr"> Specifications Context</h2>
 qPCR-based viral titer determination amplifies a conserved genomic region of the vector -- for lentivirus, commonly within the LTR or packaging signal -- and compares the resulting signal against a standard curve of known copy number to calculate vector genomes per mL of the test preparation. Because genomic titer counts total vector particles containing the packaged genome regardless of whether they are capable of productive transduction, it typically yields a higher number than functional titer, which counts only particles that successfully transduce and express in target cells; researchers calculating MOI for an experiment should be clear about which titer type they are using, since the appropriate MOI range can differ depending on which titer figure is the basis for the calculation. qPCR titer kits are typically stored at &minus;20 &deg;C, with standards and master mix components included; lot-specific CoAs are available on request. 
Ensure the accuracy of your viral dosing&mdash;<a href="https://mbpinc.net/contact-us" style="color: #236fa1;">reach out to the MBP team</a> now for a quote on our expert qPCR Titer solutions

qPCR Titer Kits

DataSheet

MSDS

ROX Machine Compatibility

qPCR AAV Titer Kit

Storage Condition

Flyer

qPCR Lentivirus Titer Kit

<h2 dir="ltr"> What Are Lentiviral Purification &amp; Packaging Kits?</h2>
 Producing high-quality lentiviral stocks is a prerequisite for reproducible transduction experiments. Low-titer or impure virus preparations reduce transduction efficiency, introduce toxicity from residual cell debris, and compromise experimental reproducibility. Purification and packaging kits address every step from plasmid transfection through virus harvest and concentration. Vector production quality depends on efficient purification and packaging workflows. Choose the kit designed for your system.
&nbsp;
<h2 dir="ltr">What you will find:</h2>
&nbsp;
<ul>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif; color: #000000;" aria-level="1">
2nd and 3rd Generation Lentivirus Bundles combining transduction enhancers, transfection reagents, packaging mix, titer kits for complete workflows
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif; color: #000000;" aria-level="1">
2nd and 3rd Generation Packaging System Mix for standardized viral production workflows
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif; color: #000000;" aria-level="1">
DNAfectin&trade; Plus and Packaging Mix systems for enhanced transfection workflows
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif; color: #000000;" aria-level="1">
Lentivirus Promoter Blast&trade; Kit for lentiviral expression studies driven by promoters
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif; color: #000000;" aria-level="1">
SARS-CoV-2 S Protein Pseudotype Lentiviral Packaging Mix for pseudovirus-based research applications
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif; color: #000000;" aria-level="1">
Ultra-Pure Lentivirus Purification Kit for viral cleanup and concentration
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif; color: #000000;" aria-level="1">
ViralEntry&trade; Transduction Enhancer for improved transduction
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif; color: #000000;" aria-level="1">
qPCR Lentivirus Titer Kit &amp; ViralEntry&trade; Bundle for optimized transduction workflows and&nbsp; viral quantification&nbsp;
</li>
</ul>
<h2 dir="ltr"> How to Choose a Purification &amp; Packaging Kit</h2>
 Concentration Method Available PEG precipitation kits work with a standard benchtop centrifuge, producing 10&ndash;100-fold concentration &mdash; the most accessible method for labs without ultracentrifuges. Ultrafiltration (100 kDa cutoff) offers high recovery (&gt;80%) while removing small molecules and unincorporated VSV-G. Ultracentrifugation provides the highest concentration (up to 1000&times;) but requires specialised equipment. Packaging Plasmid Generation 3rd generation systems (pMDLg/pRRE + pRSV-Rev + pVSV-G) split packaging elements across three plasmids and eliminate Tat for biosafety. 2nd generation systems use a single packaging plasmid + pVSV-G; some transfer vectors with RSV promoters produce lower titers with 3rd generation packaging unless using CMV-promoter variants (pLKO.1C). Starting Volume Scale Ultrafiltration units are compatible with both small-scale (&le;20 mL) and large-scale (up to 1 L) starting volumes using appropriately sized membranes. Plasmid Transfection Ratio For 3rd generation packaging, a 4:2:1:1 ratio of transfer vector:pMDLg/pRRE:pVSV-G:pRSV-Rev has been validated to maximise titer, with 20 &micro;g transfer vector per 15 cm dish as a standard starting point. Titer Assessment Method p24 ELISA measures total viral particle content; functional transduction assays (GFP or antibiotic selection) measure infectious titer; qPCR-based RNA titration measures packaged RNA copies. Functional titer is most relevant for transduction experiments. 
<h2 dir="ltr"> Specifications Context</h2>
 Lentiviral concentration workflows commonly combine PEG precipitation, ultrafiltration, or density-gradient methods to increase viral titer without requiring ultracentrifugation. Ultrafiltration systems using 100 kDa membranes efficiently retain lentiviral particles (approximately 80&ndash;120 nm) while removing smaller contaminants and free proteins. Following concentration, viral stocks are typically aliquoted into single-use volumes and stored at &minus;80 &deg;C because infectivity decreases with repeated freeze&ndash;thaw cycles and prolonged storage above freezing temperatures. Modern 2nd- and 3rd-generation packaging systems separate essential viral functions across multiple plasmids, including a dedicated VSV-G envelope plasmid, to support safer lentiviral production workflows. Product availability reflects MBP's catalogue as of mid-2026. 
&nbsp;
<a href="https://mbpinc.net/contact-us">Contact the expert team </a>at MBP Inc. and get reliable lentiviral purification and packaging kits for your lab today.

Purfication & Packaging Kits

MSDS- LV900

MSDS - G515

qPCR Lentivirus Titer Kit & ViralEntry™ Bundle

PCR & qPCR Film

Brochure

qPCR Optical Sealing film

AZ-7260 PURline™ qPCR Sealing Film by Azura Genomics — available in three variants: optically clear sticky adhesive for Bio-Rad instruments (AZ-7260), optically clear pressure-sensitive for ABI instruments (AZ-7265), and aluminum for PCR or storage (AZ-7270). All variants compatible with standard PCR plates, guaranteed below 5% evaporation, 100 sheets per pack.

Manufacturer

Sealing film, qPCR Optical (sticky adhesive film) Bio-Rad Type, 10 bags of 10 membranes

Sealing film, qPCR Optical (pressure-sensitive adhesive) ABI Type, 10 bags of 10 membranes

Aluminum Sealing Film for PCR or storage 100/pk (10 bags of 10)

qPCR Retrovirus Titer Kit

<h2 dir="ltr">What Are AAV and Adenovirus CRISPR Delivery Systems?</h2>
 AAV and adenovirus-based delivery systems exploit the natural cell-entry machinery of these viruses to deliver Cas9 and guide RNA cargo into cells that resist conventional transfection &mdash; including primary cells, stem cells, neurons, and in vivo tissues. AAV is the most widely used viral vector for CRISPR-based gene editing, valued for high transduction efficiency, low immunogenicity, and an established safety profile in human gene therapy. The right viral delivery system influences transduction efficiency, expression profile, and genome-editing outcomes. AAV and adenoviral vectors offer distinct advantages depending on your research goals.
&nbsp;
<h2 dir="ltr">What you will find:</h2>
&nbsp;
<ul>
<li data-section-id="17k5oh4" data-start="0" data-end="142">Adenoviral Cas9 &amp; Nickase Nucleases: Viral delivery systems for rapid, transient Cas9 or nickase expression without genomic integration.</li>
<li data-section-id="12kolej" data-start="144" data-end="280">AAV6 &amp; AAV8 Viral Vectors: Serotype-specific AAV vectors optimized for transduction of hematopoietic stem cells and liver tissues.</li>
<li data-section-id="81toc4" data-start="282" data-end="412">saCas9 AAV Serotypes (1&ndash;10): Diverse AAV serotypes designed to support targeted cellular tropism across CRISPR applications.</li>
<li data-section-id="18h5j1a" data-start="414" data-end="554">Ampicillin-Selected AAV Vectors: AAV vector backbones containing ampicillin resistance markers for cloning and transformant selection.</li>
<li data-section-id="xfx9g1" data-start="556" data-end="697" data-is-last-node="">High-Titer Viral Particles: Purified viral preparations optimized to maintain genomic integrity and minimize endotoxin-related effects.</li>
</ul>
<h2 dir="ltr"> How to Choose AAV/Adenovirus CRISPR Delivery</h2>
 Genome Capacity Requirements AAV's ~4.7 kb packaging capacity is too small for full-length SpCas9 (~4.2 kb) plus a promoter and guide RNA. Split-vector systems (Cas9 across two AAV particles) or compact Cas9 orthologs such as SaCas9 (~3.2 kb) address this limit. Adenovirus offers 34&ndash;43 kb capacity for larger cargo. Serotype and Tissue Tropism AAV serotypes differ in their ability to transduce specific cell types and tissues, making serotype selection an important part of CRISPR delivery design. The optimal serotype depends on the target tissue, model system, administration route, and experimental goals. MBP offers saCas9 AAV viruses in multiple serotypes (AAV1&ndash;AAV11) to support a range of research applications. Cell Division Status Both AAV and adenovirus transduce dividing and non-dividing cells, making them suitable for primary neurons, hepatocytes, and other post-mitotic populations that resist standard transfection. Immunogenicity Considerations AAV has low immunogenicity and minimal integration risk, supporting widespread pre-clinical and clinical in vivo use. Adenovirus offers higher initial transduction efficiency and larger cargo capacity but generates a stronger immune response, which can limit in vivo utility. Packaging System Helper-free packaging systems eliminate the need for replication-competent helper virus, designed for BSL-2 containment &mdash; though institutional biosafety committee (IBC) approval is required before starting viral vector work. 
<h2 dir="ltr"> Specifications Context</h2>
 AAV and adenoviral CRISPR delivery systems support retinal gene therapy models, CNS editing studies, liver-targeted in vivo CRISPR, muscle cell engineering, primary immune cell editing, iPSC-derived cell modification, and genome-modified animal model generation. Capsid engineering through directed-evolution platforms continues to expand AAV tropism options, including enhanced CNS penetration following systemic delivery, an active area of pre-clinical research relevant to labs planning long-term in vivo programs. All recombinant AAV production and adenoviral vector work requires IBC approval at BSL-2 containment in most jurisdictions; MBP can provide biosafety classification documentation. Product availability reflects MBP's catalogue as of mid-2026. 
&nbsp;
Reach out to the professional <a href="https://mbpinc.net/contact-us" style="color: #236fa1; text-decoration: underline;">team at MBP Inc</a>. now to ask for a quote for a suitable AAV or Adenovirus system for your lab.